PEN Penumbra, Inc. Loading... : Bullish and Bearish Analyst Opinions
From SYK earnings callsLoading chart...
Top Calls
Feed
21:30
Jan 29
Jan 29
Stryker acknowledged its ischemic neurovascular business has been pressured for two years, with a new large-bore aspiration catheter only in early US launch, while hemorrhagic has overtaken market leadership — a mixed competitive signal for neurovascular rivals. — Competitors in ischemic stroke aspiration still have a window before Stryker's Broadway launch scales globally, while Stryker's hemorrhagic strength raises the bar in that segment.
MED
About PEN Analyst Coverage
Buzzberg tracks PEN (Penumbra, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Jason Beach.